Company · CIK 1540171

# Avalyn Pharma Inc.

| CIK | [1540171](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001540171) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | AVLN (Nasdaq) |
| First annual or quarterly report | 2026-06-03 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-294932 | IPO Final prospectus | 2026-04-08 | 2026-04-30 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-04-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1540171/000119312526197686/0001193125-26-197686-index.htm) Final prospectus | 333-294932 | 0001193125-26-197686 |
| 2026-04-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1540171/999999999526001383/9999999995-26-001383-index.htm) Declared effective | 333-294932 | 9999999995-26-001383 |
| 2026-04-29 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1540171/000119312526189477/0001193125-26-189477-index.htm) Amendment | 333-294932 | 0001193125-26-189477 |
| 2026-04-23 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1540171/000119312526173632/0001193125-26-173632-index.htm) Amendment | 333-294932 | 0001193125-26-173632 |
| 2026-04-08 | [S-1](https://www.sec.gov/Archives/edgar/data/1540171/000119312526147573/0001193125-26-147573-index.htm) Registration filed | 333-294932 | 0001193125-26-147573 |
| 2026-02-06 | [DRS](https://www.sec.gov/Archives/edgar/data/1540171/000119312526040979/0001193125-26-040979-index.htm) Draft made public | 377-09014 | 0001193125-26-040979 |

[All filings of this company](https://equitycapital.markets/filings?cik=1540171) · [CSV](https://equitycapital.markets/filings.csv?cik=1540171)

---
Source page: https://equitycapital.markets/company/1540171 · Data: U.S. SEC EDGAR · CC BY 4.0